✦ LIBER ✦

Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer

✍ Scribed by Christopher M. Stephenson, Robert D. Levin…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I dose-escalation study to evalu

✍ Desar, I M E; Timmer-Bonte, J N H; Burger, D M; van der Graaf, W T A; van Herpen 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 349 KB

Phase I clinical trial to determine maxi

✍ Mohammad H. Pourgholami; Michael Szwajcer; Melvin Chin; Winston Liauw; Jonathan 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 341 KB

Phase I clinical and pharmacokinetics st

✍ James Bishop; Robin Murray; Lorraine Webster; Paula Pitt; Kerrie Stokes; Anne Fe 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 598 KB

A phase I/II dose escalating trial evalu

✍ P. Marcellin; G.K.K. Lau; H. Mommeja-Marin; S. Sacks; D. Sereni; J.P. Bronowicki 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A Phase I study to assess the safety, to

✍ J. R. Infante; R. Kurzrock; J. Spratlin; H. A. Burris; S. G. Eckhardt; J. Li; K. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 338 KB

A phase 1 open-label, sequential dose-es

✍ Ghamande, Sharad; Lin, Chia-Chi; Cho, Daniel C.; Shapiro, Geoffrey I.; Kwak, Eun 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 318 KB